天工国际(00826.HK)拟分拆附属天工工具於内地上市
天工国际(00826.HK)公布,为整合资源及扩充强化高速钢及模具钢业务,计划分拆附属公司天工工具於中国境内一家证券交易所独立上市,董事会已授权公司及天工工具管理层启动拟分拆事项的前期筹备工作,包括但不限於可行性计划研究、组织编制上市方案、签署筹划过程中涉及的相关协议等上市相关事宜。
天工国际表示,目前持有天工工具82.35%股份,为其控股股东,天工工具已完成股权激励、引入战略投资者等相关工作,预期分拆不会导致公司丧失对天工工具的控制权,天工工具仍会为旗下附属公司, 料不会损害公司独立上市地位和持续盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.